In the last year, BenQ Medical Technology's Price has seen a drop from NT$76.39 to NT$0.00 – a 100.00% decrease. In the next year, analysts believe that Fair Value will reach NT$0.00 – an increase of 100.00%. For the next six years, the forecast is for Fair Value to grow by 100.00%.

2025 Fair Value Forecast

NT$0.00

2026 Fair Value Forecast

NT$0.00

2027 Fair Value Forecast

NT$0.00

2028 Fair Value Forecast

NT$0.00

2029 Fair Value Forecast

NT$0.00

2030 Fair Value Forecast

NT$0.00

BenQ Medical Technology Revenue Forecast for 2023 - 2025 - 2030

In the last three years, BenQ Medical Technology's Revenue has grown, rising from NT$1.40B to NT$4.54B – a growth of 224.30%. According to 0 major analysts, BenQ Medical Technology's Revenue will fall by 29.92% in the next year, reaching NT$3.18B. Professionals believe that By 2030, BenQ Medical Technology's Revenue will fall to NT$3.11B– a 31.60% decrease from its current value.

2024 Rev Forecast

NT$3.18B

2025 Rev Forecast

NT$2.73B

2026 Rev Forecast

NT$2.95B

2027 Rev Forecast

NT$3.46B

2028 Rev Forecast

NT$3.40B

2029 Rev Forecast

NT$3.17B

2030 Rev Forecast

NT$3.11B

BenQ Medical Technology Dividend per Share Forecast for 2023 - 2025 - 2030

BenQ Medical Technology's Dividend per Share has grown In the last three years, rising from NT$1.00 to NT$2.00 – a growth of 100.00%. In the next year, analysts believe that Dividend per Share will reach NT$2.19 – an increase of 9.60%. According to professional forecasts, in 2030, BenQ Medical Technology's Dividend per Share will decrease by 7.71%, reaching NT$1.85.

2024 DPS Forecast

NT$2.19

2025 DPS Forecast

NT$1.61

2026 DPS Forecast

NT$1.78

2027 DPS Forecast

NT$1.89

2028 DPS Forecast

NT$2.02

2029 DPS Forecast

NT$1.87

2030 DPS Forecast

NT$1.85

BenQ Medical Technology Free Cash Flow Forecast for 2023 - 2025 - 2030

BenQ Medical Technology EBITDA Forecast for 2023 - 2025 - 2030

In the last three years, BenQ Medical Technology's EBITDA has grown by 264.44%, rising from NT$146.02M to NT$532.15M. In the following year, 0 experts forecast that BenQ Medical Technology's EBITDA will decrease by 23.55%, to NT$406.81M. In 2030, professionals predict that BenQ Medical Technology's EBITDA will decrease by 32.85%, to NT$357.33M.

2024 EBITDA Forecast

NT$0.41B

2025 EBITDA Forecast

NT$0.30B

2026 EBITDA Forecast

NT$0.33B

2027 EBITDA Forecast

NT$0.39B

2028 EBITDA Forecast

NT$0.40B

2029 EBITDA Forecast

NT$0.37B

2030 EBITDA Forecast

NT$0.36B

BenQ Medical Technology EBIT Forecast for 2023 - 2025 - 2030

In the last three years, BenQ Medical Technology's EBIT has grown, moving from NT$97.21M to NT$365.44M – an increase of 275.93%. 0 analysts predict BenQ Medical Technology's EBIT will decrease by 5.23% in the next year, reaching NT$346.34M. By 2030, professionals predict that BenQ Medical Technology's EBIT will decrease by 29.70%, to NT$256.89M.

2024 EBIT Forecast

NT$0.35B

2025 EBIT Forecast

NT$0.21B

2026 EBIT Forecast

NT$0.22B

2027 EBIT Forecast

NT$0.27B

2028 EBIT Forecast

NT$0.31B

2029 EBIT Forecast

NT$0.27B

2030 EBIT Forecast

NT$0.26B

BenQ Medical Technology EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last year, BenQ Medical Technology's EPS has seen a drop from NT$3.01 to NT$0.00 – a 100.00% decrease. In the next year, analysts believe that EPS will reach NT$0.00 – an increase of 100.00%. For the next six years, the forecast is for EPS to grow by 100.00%.

2025 EPS Forecast

NT$0.00

2026 EPS Forecast

NT$0.00

2027 EPS Forecast

NT$0.00

2028 EPS Forecast

NT$0.00

2029 EPS Forecast

NT$0.00

2030 EPS Forecast

NT$0.00